fashion -WSS

fashion

author：entertainment 2025-08-12 11:29:48 - browse：99252

TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： The tragedy of Johnson & Johnson’s Covid vaccine

WSS

Zyn nicotine pouches become unlikely player in latest culture war

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Biotech venture capitalists face new demands from investors

AI generated plenty of interest at JPM but not a lot of trust

Why doctors need education on FDA device approval process

Wikipedia

fashion

entertainment

The high cost of giving birth even with insurance

10 reasons why health care startups fail

Supreme Court strikes down use of affirmative action

Health Care Service Corp to buy Cigna Medicare Advantage plans

Heart attack and stroke risk calculators need revising

Dewpoint Therapeutics lays off staff after losing partnerships

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Walensky prepares to leave CDC — and Congress — behind

Independent physicians launch a new lobbying group

hotspot

Philips to halt sales of sleep apnea machines in U.S.

Why you shouldn’t ask, “What country has the best health care?”

The surgeon had a dilemma only a Nazi medical text could resolve

Think you might have Covid

Merck, Johnson & Johnson CEOs will testify on high drug prices

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Wikipedia

leisure time

Wikipedia

hotspot